Lancet, J.E.
Lin, T.L.
Hogge, D.
Solomon, S.R.
Schiller, G.J.
Wieduwilt, M.J.
Martin, R.
Faderl, S.
Chang, Y.
Cortes, J.E.
This article is maintained by: Elsevier
Article Title: FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)
Journal Title: Hematology, Transfusion and Cell Therapy
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2020.10.257
Content Type: simple-article
Copyright: